Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE
01-03-2007
REPORT TYPE
Annual Summary
DATES COVERED
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTESOriginal contains colored plates: ALL DTIC reproductions will be in black and white.
ABSTRACTCurrently we designed and implemented a combined spectral and lifetime imaging system which combines the benefits of multiphoton microscopy, spectral discrimination, lifetime analysis and temporal information. This system has efficiencies of > 50% and capability to collect broad spectrums (from 380nm-700nm). We determined the fluorescence source under our imaging condition is from NADH by this combined spectral and lifetime imaging system. Furthermore, we validated the accuracy of our lifetime analysis method. Our preliminary results of metabolic mapping in different human breast cell lines via fluorescence lifetime measurement of Co-Enzyme NADH showed very interesting results in differences of the lifetime and contribution of bound NADH between human normal breast cell line (MCF10a) and human breast cancer cell lines (T47D and MBA_MD_231). A 2-Deoxy-D-glucose (2DG) perturbation study is underway to link these finds with glycolysis.
SUBJECT TERMSBreast Cancer, Metabolism, Lifetime, Spectra, Multiphoton The goal of this research is to apply a recently developed novel non-linear imaging modality(2), which combines current state of the art imaging techniques (fluorescence spectroscopy and fluorescence lifetime) with multiphoton microscopy into an integrated system. This system is designed to collect all the information in the fluorescence signal and exploit this information to demonstrate the potential for imaging endogenous fluorescence signatures in breast cancer cell models. We expect that this new combined spectral lifetime imaging modality will help for 5 characterization of breast cancer cells from cell culture based models to a relevant in vitro tumorhost environment and eventually to in vivo tumor models.
BODY:In order to most effectively discriminate and characterize fluorescence sources in living samples, one n...